Oncopeptides AB (ONCO) — Strategic Asset Allocation Index
Oncopeptides AB (ONCO) has a Strategic Asset Allocation Index of 304.6% as of September 2025. Strategic assets (PP&E of Skr19.91 Million plus long-term investments of Skr-) total Skr19.91 Million, measured against net assets of Skr6.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Oncopeptides AB Strategic Asset Allocation Index (2014–2024)
This chart shows how Oncopeptides AB's Strategic Asset Allocation Index has evolved across 10 annual periods from 2014 to 2024. As of September 2025, the index stands at 304.6%, representing strategic assets of Skr19.91 Million against net assets of Skr6.54 Million SEK. Explore Oncopeptides AB (ONCO) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Oncopeptides AB (2014–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Oncopeptides AB from 2014 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Oncopeptides AB stock valuation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 49.9% | Skr27.11 Million | Skr27.11 Million | Skr- | Skr54.28 Million | ▼ -11.0 pp |
| 2023 | 61.0% | Skr34.63 Million | Skr34.63 Million | Skr- | Skr56.78 Million | ▲ +54.0 pp |
| 2022 | 6.9% | Skr20.44 Million | Skr20.44 Million | Skr- | Skr294.29 Million | ▼ -4.8 pp |
| 2021 | 11.7% | Skr24.74 Million | Skr24.74 Million | Skr- | Skr210.87 Million | ▲ +5.1 pp |
| 2020 | 6.6% | Skr38.33 Million | Skr38.33 Million | Skr- | Skr576.90 Million | ▲ +4.1 pp |
| 2019 | 2.6% | Skr20.49 Million | Skr17.19 Million | Skr3.30 Million | Skr797.01 Million | ▲ +1.8 pp |
| 2018 | 0.7% | Skr2.36 Million | Skr2.36 Million | Skr- | Skr315.83 Million | ▲ +0.1 pp |
| 2017 | 0.6% | Skr2.60 Million | Skr2.34 Million | Skr263.00K | Skr418.00 Million | ▼ -3.6 pp |
| 2016 | 4.2% | Skr1.10 Million | Skr1.10 Million | Skr- | Skr26.34 Million | ▲ +4.0 pp |
| 2014 | 0.2% | Skr15.00K | Skr15.00K | Skr- | Skr7.61 Million | — |